Publication | Closed Access

High post‐treatment platelet reactivity identified low‐responders to dual antiplatelet therapy at increased risk of recurrent cardiovascular events after stenting for acute coronary syndrome

Percutaneous Coronary InterventionThrombosisDual Antiplatelet TherapyCardiovascular DiseaseBlood PlateletRecurrent Cardiovascular EventsAcute Coronary SyndromeAcute Myocardial InfarctionPlatelet AntagonistMedicineAtherosclerosisEmergency MedicineCoronary Artery Disease